World Journal of
Pharmaceutical and Life Sciences

CLINICAL EVALUATION OF ARAGVADHADI SUTRA IN THE MANAGEMENT OF BHAGANDARA

Dr. Pushpa Chhangani*

ABSTRACT

Anal fistula is a common problem that causes substantial morbidity in persons who are otherwise healthy. It is one in which a patient experiences pain, discharge and un-comfortness etc. Owing to the numerous surgical complications while treating the disease, the Ksharsutra therapy came as a breakthrough and Aragvadhadi sutra was accepted as the standardized one. This study was conducted to evaluate the effectiveness of Aragvadhadi sutra in the management of Bhagandara (Fistula-in-ano). A total of 40 patients were included in this study on inclusion criteria and divided into two equal groups. Trial group treated with Aragvadhadi sutra and control group treated with Standard Ksharsutra. Assessment was made on pain and objective (Nadi Chedan Kala) parameters. Observations were made before the treatment and on every 7th day of the therapy until complete cutting of the track. This study reveals that in group A the patients had Grade II, III and IV severity of pain and in group B the pain grade was observed as Grade I, II and III. In Group A (Standard Ksharsutra) the Nadi Chedan Kala was 0.91 cm/week and in Group B (Aragvadhadi sutra) the Nadi Chedan Kala was 0.84 cm/week. The study showed that the trial drug Aragvadhadi sutra was as good as the standard Ksharsutra in the treatment of Bhagandara.

[Full Text Article]   [Download Certificate]